Get a Canadian Regulatory Intelligence Update Delivered to Your Inbox Every Week
The Canadian Regulatory Intelligence Update, published by TPIreg™, the regulatory division of Innomar Strategies, provides the following updates on a weekly basis:
All updates related to drugs and devices from Health Canada, issued through the
Biologic and Radiopharmaceutical Drugs Directorate (BRDD),
Therapeutic Products Directorate (TPD),
Marketed Health Products Directorate (MHPD),
Medical Devices Directorate (MDD),
Non-prescription and Natural Health Products Directorate (NNHPD) and
Drug Establishment Licencing (DEL) updates
All updates issued from the Canadian Agency for Drugs and Technologies in Health (CADTH)
All updates issued from Patented Medicine Prices Review Board (PMPRB)
All updates issued from Pharmaceutical Advertising Advisory Board (PAAB)
All updates issued from Canadian Environmental Protection Agency (CEPA) related to drugs
Monitor Foreign Safety Updates
Weekly Foreign Authorities Safety Update
Health Canada also requires the submission of foreign safety updates. In addition to our regulatory intelligence publication, our weekly Foreign Authorities Safety Update provides updates, including recalls and safety notices, from the countries that Health Canada is expecting you to monitor, including the U.S., Switzerland, France, and many more. The information provided is collected from all countries that have a searchable database and is aggregated by generic name.
Any company can easily verify if a drug they sell is covered and determine if there is a need to alert Health Canada within the prescribed 72-hour period.
Purchase an Annual Subscription
Subscribe to either the Canadian Regulatory Intelligence Update or the Foreign Authorities Safety Update for $2000.00 CDN each or purchase a subscription to both publications for $3000.00 CDN. An invoice will be sent following your submission.